Coen Stacy Ann — SEC Form 4 filings
SEC reporting owner CIK 1814150. 5 Form 4 filings on record with FilingPulse; latest filed 2025-06-12.
Transaction summary — filings shown
Covers all 5 filings on record, filed 2024-02-05 to 2025-06-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 4,583 shares, $134,282 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 12.
- Largest priced transaction: sale of 4,583 shares @ $29.30 ($134,282) in ImmunoGen, Inc., filed 2024-02-06.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ImmunoGen, Inc. (IMGN) | SVP & CHIEF BUSINESS OFFICER | 3 | — | 1 leg · 4,583 sh · $134,282 | 10 |
| FibroBiologics, Inc. (FBLG) | Director | 2 | — | — | 2 |
Form 4 filings — Coen Stacy Ann
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2025-06-12 | 4 | FibroBiologics, Inc. (FBLG) | Grant/award (A): 22,000 (derivative) @ $0 | EDGAR |
| 2024-08-27 | 4 | FibroBiologics, Inc. (FBLG) | Grant/award (A): 5,000 (derivative) @ $0 | EDGAR |
| 2024-02-12 | 4 | ImmunoGen, Inc. (IMGN) | Disposition to issuer (D): 73,274 · Disposition to issuer (D): 150,610 (derivative) · Disposition to issuer (D): 303,465 (derivative) · Disposition to issuer (D): 258,195 (derivative) · Disposition to issuer (D): 65,000 (derivative) · Disposition to issuer (D): 28,700 (derivative) · +1 more | EDGAR |
| 2024-02-06 | 4 | ImmunoGen, Inc. (IMGN) | Option exercise (M): 14,350 @ $0 · Sale (S): 4,583 @ $29.30 · Option exercise (M): 14,350 (derivative) @ $0 | EDGAR |
| 2024-02-05 | 4 | ImmunoGen, Inc. (IMGN) | Grant/award (A): 39,293 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1814150 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →